GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immutep Ltd (STU:YP1B) » Definitions » Dividend Yield %

Immutep (STU:YP1B) Dividend Yield % : 0.00% (As of Dec. 14, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Immutep Dividend Yield %?

As of today (2024-12-14), the Trailing Annual Dividend Yield of Immutep is 0.00%.

The historical rank and industry rank for Immutep's Dividend Yield % or its related term are showing as below:

STU:YP1B's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.39
* Ranked among companies with meaningful Dividend Yield % only.

Immutep's Dividend Payout Ratio for the three months ended in Jun. 2024 was 0.00.

As of today (2024-12-14), the Forward Dividend Yield % of Immutep is 0.00%.

Immutep's Dividends per Share for the three months ended in Jun. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Immutep Dividend Yield % Historical Data

The historical data trend for Immutep's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immutep Dividend Yield % Chart

Immutep Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Immutep Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Immutep's Dividend Yield %

For the Biotechnology subindustry, Immutep's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immutep's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immutep's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Immutep's Dividend Yield % falls into.



Immutep Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Immutep  (STU:YP1B) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Immutep Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Immutep's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Immutep Business Description

Traded in Other Exchanges
Address
264 George Street, Level 32, Australia Square, Sydney, NSW, AUS, 2000
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

Immutep Headlines

No Headlines